InnovAge Holding (INNV) | Financial Analysis & Statements
InnovAge Holding Corp. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
236.1M
Gross Profit
51.4M
21.75%
Operating Income
8.4M
3.55%
Net Income
7.7M
3.25%
EPS (Diluted)
$0.06
Balance Sheet Metrics
Total Assets
527.5M
Total Liabilities
238.7M
Shareholders Equity
288.8M
Debt to Equity
0.83
Cash Flow Metrics
Operating Cash Flow
4.9M
Free Cash Flow
9.2M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
InnovAge Holding Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 853.7M | 763.9M | 688.1M | 698.6M | 637.8M |
| Cost of Goods Sold | 700.1M | 631.8M | 586.8M | 563.3M | 463.7M |
| Gross Profit | 153.6M | 132.1M | 101.3M | 135.4M | 174.1M |
| Gross Margin % | 18.0% | 17.3% | 14.7% | 19.4% | 27.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 150.3M | 136.3M | 135.3M | 125.9M | 154.6M |
| Other Operating Expenses | - | - | - | - | 18.2M |
| Total Operating Expenses | 150.3M | 136.3M | 135.3M | 125.9M | 172.8M |
| Operating Income | -16.1M | -23.2M | -49.4M | -4.4M | -11.0M |
| Operating Margin % | -1.9% | -3.0% | -7.2% | -0.6% | -1.7% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 4.6M | 4.0M | 1.5M | 2.5M | 16.8M |
| Other Non-Operating Income | -13.3M | 5.4M | 124.0K | -305.0K | -7.2M |
| Pre-tax Income | -34.0M | -21.8M | -50.8M | -7.2M | -35.0M |
| Income Tax | 1.3M | 1.4M | -7.2M | 723.0K | 9.8M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -35.3M | -23.2M | -43.6M | -8.0M | -44.7M |
| Net Margin % | -4.1% | -3.0% | -6.3% | -1.1% | -7.0% |
| Key Metrics | |||||
| EBITDA | 3.7M | 1.2M | -33.9M | 9.2M | 8.6M |
| EPS (Basic) | - | $-0.16 | $-0.30 | $-0.05 | $-0.36 |
| EPS (Diluted) | - | $-0.16 | $-0.30 | $-0.05 | $-0.36 |
| Basic Shares Outstanding | - | 135902214 | 135593824 | 135519970 | 123618702 |
| Diluted Shares Outstanding | - | 135902214 | 135593824 | 135519970 | 123618702 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
InnovAge Holding Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 64.1M | 56.9M | 127.2M | 184.4M | 201.5M |
| Short-term Investments | 41.8M | 45.8M | 46.2M | 0 | - |
| Accounts Receivable | 36.4M | 48.1M | 24.3M | 35.9M | 32.6M |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | 13.8M | 9.2M |
| Total Current Assets | 176.1M | 173.1M | 215.2M | 241.0M | 250.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 26.9M | 28.4M | 21.2M | 47.5M | 35.3M |
| Goodwill | 288.0M | 284.4M | 253.6M | 254.3M | 255.0M |
| Intangible Assets | 3.9M | 4.5M | 5.2M | 5.9M | 6.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 9.9M | 5.9M | 3.8M | 2.8M | - |
| Total Non-Current Assets | 350.7M | 374.5M | 352.1M | 314.6M | 280.8M |
| Total Assets | 526.9M | 547.7M | 567.4M | 555.6M | 531.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 76.8M | 55.5M | 54.9M | 50.6M | 32.4M |
| Short-term Debt | 12.2M | 12.5M | 12.0M | 7.2M | 5.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 61.5M | 55.4M | 43.0M | 38.5M | 33.2M |
| Total Current Liabilities | 164.8M | 138.6M | 148.4M | 105.3M | 78.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | 88.9M | 100.5M | 96.8M | 77.6M | 76.8M |
| Deferred Tax Liabilities | 8.8M | 7.5M | 6.2M | 17.8M | 15.7M |
| Other Non-Current Liabilities | 1.5M | 1.3M | 1.1M | 1.1M | 2.8M |
| Total Non-Current Liabilities | 99.1M | 109.3M | 104.1M | 96.5M | 95.2M |
| Total Liabilities | 263.9M | 247.9M | 252.6M | 201.9M | 173.8M |
| Equity | |||||
| Common Stock | 137.0K | 136.0K | 136.0K | 136.0K | 136.0K |
| Retained Earnings | -101.0M | -68.3M | -35.9M | 4.7M | 10.7M |
| Treasury Stock | 7.5M | 179.0K | 0 | 0 | 0 |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 262.9M | 299.8M | 314.8M | 353.7M | 358.0M |
| Key Metrics | |||||
| Total Debt | 101.1M | 113.0M | 108.8M | 84.8M | 82.6M |
| Working Capital | 11.3M | 34.5M | 66.8M | 135.6M | 172.4M |
Balance Sheet Composition
InnovAge Holding Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -35.3M | -23.2M | -43.6M | -8.0M | -44.7M |
| Depreciation & Amortization | 19.5M | 19.0M | 15.4M | 13.9M | 12.3M |
| Stock-Based Compensation | 7.6M | 6.8M | 4.6M | 3.7M | 1.7M |
| Working Capital Changes | 26.5M | -53.5M | 49.0M | 11.7M | 11.0M |
| Operating Cash Flow | 28.1M | -45.3M | 19.1M | 23.9M | -12.3M |
| Investing Activities | |||||
| Capital Expenditures | -6.3M | -7.9M | -23.4M | -38.2M | -17.5M |
| Acquisitions | -3.5M | -19.1M | 0 | - | - |
| Investment Purchases | -2.1M | -2.4M | -46.2M | -2.0M | 0 |
| Investment Sales | 6.3M | 3.0M | 0 | - | - |
| Investing Cash Flow | -5.6M | -26.4M | -69.5M | -40.2M | -17.5M |
| Financing Activities | |||||
| Share Repurchases | -7.3M | -179.0K | 0 | 0 | -77.6M |
| Dividends Paid | - | - | - | 0 | -9.5M |
| Debt Issuance | - | - | - | 0 | 375.0M |
| Debt Repayment | -9.9M | -8.4M | -7.9M | -6.3M | -514.4M |
| Financing Cash Flow | -19.1M | -7.0M | -7.9M | -6.3M | 116.2M |
| Free Cash Flow | 26.6M | -44.8M | -3.1M | -10.9M | -27.1M |
| Net Change in Cash | 3.5M | -78.7M | -58.3M | -22.6M | 86.3M |
Cash Flow Trend
InnovAge Holding Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
152.00
Forward P/E
22.35
Price to Book
4.02
Price to Sales
1.13
PEG Ratio
-0.84
Profitability Ratios
Profit Margin
0.71%
Operating Margin
5.53%
Return on Equity
1.18%
Return on Assets
2.92%
Financial Health
Current Ratio
1.26
Debt to Equity
33.02
Beta
0.50
Per Share Data
EPS (TTM)
$0.05
Book Value per Share
$1.89
Revenue per Share
$6.76
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| INNV | 1.1B | 152.00 | 4.02 | 1.18% | 0.71% | 33.02 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






